Compounded tirzepatide prescriptions are limited to residents in the following states: AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, TN, TX, UT, VA, VT, WA, WI, WV, Washington D.C., WY
And for specific fat distribution concerns, guides on peptides for belly fat , best fat-burning peptides , and visceral fat loss provide targeted information
For the first week or two, tirzepatide is still providing most of the GLP-1 receptor activation
2 Based on available evidence, there have been no cases of MTC in humans linked to GLP-1 RAs
[PMID: 3198322] PubMed record related to this compound for laboratory literature review